Regorafenib in Relapsed Glioblastoma

Clinical trial NCT02926222 · COMPLETED

Trial details

NCT number: NCT02926222
Sponsor: Istituto Oncologico Veneto IRCCS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2015-11-01
Primary completion: 2017-07-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.